SCHEMBL1885800

SCHEMBL1885800

CC(C)(C)[Si](C)(C)Oc1ccc2cc3c(cc2c1)C(=O)c1cc2cc(O[Si](C)(C)C(C)(C)C)ccc2cc1C3=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.61
CA1 P00915 4/20 0.61
CA9 Q16790 4/20 0.61
PREP P48147 4/20 0.46
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
GSTP1 P09211 1/20 0.34
MAOB P27338 3/20 0.33
CYP2A6 P11509 1/20 0.33
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PLA2G1B P04054 1/20 0.32
NFKB1 P19838 1/20 0.32
CASP3 P42574 1/20 0.32
RAB9A P51151 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1882570 1.00 CA12 (0.61) CA12CA1CA9PREPHSP90AA1
SCHEMBL4938350 0.86 CA12 (0.54) CA12CA1CA9PREPNPC1
SCHEMBL8675809 0.81 CA12 (0.49) CA12CA1CA9PREPNPC1
SCHEMBL12017833 0.79 CA1 (0.59) CA12CA1CA9PREPHSP90AA1
SCHEMBL2221888 0.78 CA12 (0.55) CA12CA1CA9PREPCYP2A6
SCHEMBL12581975 0.78 CA12 (0.55) CA12CA1CA9PREPHSP90AA1
SCHEMBL30186537 0.77 CA12 (0.58) CA12CA1CA9PREPCYP2A6
SCHEMBL704912 0.77 CA12 (0.58) CA12CA1CA9PREPCYP2A6
SCHEMBL3145017 0.77 CA1 (0.51) CA12CA1CA9PREPL3MBTL1
SCHEMBL2222733 0.77 CA12 (0.54) CA12CA1CA9PREPHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7935836-B2 Compounds comprising a linear series of five fused carbon rings, and preparation thereof FALLIS ALEXANDER GRAHAM 2011-05-03 US disclosed
US-20100004467-A1 COMPOUNDS COMPRISING A LINEAR SERIES OF FIVE FUSED CARBON RINGS, AND PREPARATION THEREOF FALLIS ALEXANDER GRAHAM 2010-01-07 US disclosed
US-20060267004-A1 Compounds comprising a linear series of five fused carbon rings, and preparation thereof UNIVERSITY OF OTTAWA (CA) 2006-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004467-A1 COMPOUNDS COMPRISING A LINEAR SERIES OF FIVE FUSED CARBON RINGS, AND PREPARATION THEREOF JUP, CDH1, EML4 CA12 926/4885CA1 1324/4885CA9 1102/4885
US-20060267004-A1 Compounds comprising a linear series of five fused carbon rings, and preparation thereof JUP, LATS2, CDH1 CA12 1813/4885CA1 1374/4885CA9 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.